BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4029274)

  • 1. Analysis of the expression of the 4F2 surface antigen in normal and neoplastic fibroblastic human cells of embryonic and adult origin.
    Azzarone B; Malpièce Y; Zaech P; Moretta L; Fauci A; Suarez H
    Exp Cell Res; 1985 Aug; 159(2):451-62. PubMed ID: 4029274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin.
    Azzarone B; Suarez H; Mingari MC; Moretta L; Fauci AS
    J Cell Biol; 1984 Mar; 98(3):1133-7. PubMed ID: 6538202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution in the structure and distribution of 4F2-antigen from the oncofetal to the adult phenotype of human fibroblasts.
    Azzarone B; Eid P; Malpiece Y; Andeol Y; Fauci AS; Suarez H
    Int J Cancer; 1986 Aug; 38(2):177-81. PubMed ID: 3525420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A target structure for a series of human cloned natural killer cell lines is recognized by both anti-TNKtar and 4F2 monoclonal antibodies.
    Moingeon P; Nowill A; Courtois G; Azzarone B; Motte P; Ythier A; Bohuon C; Hercend T
    J Immunol; 1985 May; 134(5):2930-4. PubMed ID: 3980986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The monoclonal antibodies Trop-4 and 4F2 detect the same membrane antigen that is expressed at an early stage of lymphocyte activation and is retained on secondary lymphocytes.
    Suomalainen HA
    J Immunol; 1986 Jul; 137(2):422-7. PubMed ID: 3487571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
    Kehrl JH; Muraguchi A; Fauci AS
    J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual parameter flow cytometric analysis of DNA content, activation antigen expression, and T cell subset proliferation in the human mixed lymphocyte reaction.
    Williams JM; Loertscher R; Cotner T; Reddish M; Shapiro HM; Carpenter CB; Strominger JL; Strom TB
    J Immunol; 1984 May; 132(5):2330-7. PubMed ID: 6325537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human 4F2 antigen: evidence for cryptic and noncryptic epitopes and for a role of 4F2 in human T lymphocyte activation.
    Freidman AW; Diaz LA; Moore S; Schaller J; Fox DA
    Cell Immunol; 1994 Apr; 154(1):253-63. PubMed ID: 7510581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new epitope of the 4F2/44D7 molecular complex present on sarcolemma and isolated cardiac fibers.
    Bellone G; Alloatti G; Levi R; Geuna M; Tetta C; Peruzzi L; Letarte M; Malavasi F
    Eur J Immunol; 1989 Jan; 19(1):1-8. PubMed ID: 2465900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of monoclonal antibody (4F2) to its cell surface antigen on dispersed adenomatous parathyroid cells raises cytosolic calcium and inhibits parathyroid hormone secretion.
    Posillico JT; Srikanta S; Eisenbarth G; Quaranta V; Kajiji S; Brown EM
    J Clin Endocrinol Metab; 1987 Jan; 64(1):43-50. PubMed ID: 3782435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx.
    Esteban F; Ruiz-Cabello F; Concha A; Perez Ayala M; Delgado M; Garrido F
    Cancer; 1990 Oct; 66(7):1493-8. PubMed ID: 2208000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of human colonic epithelium to express the 4F2 antigen, the common acute lymphoblastic leukemia antigen, and the transferrin receptor. Studies in inflammatory bowel disease and after in vitro exposure to different stimuli.
    Fais S; Pallone F
    Gastroenterology; 1989 Dec; 97(6):1435-41. PubMed ID: 2531100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth.
    Quackenbush E; Clabby M; Gottesdiener KM; Barbosa J; Jones NH; Strominger JL; Speck S; Leiden JM
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6526-30. PubMed ID: 3476959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2.
    Lumadue JA; Glick AB; Ruddle FH
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9204-8. PubMed ID: 3480538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of expression of cell surface antigen Mr 74,000 phosphoglycoprotein in normal, oncogene-transformed, and neoplastic rat cell lines.
    Ames RS; North SM; Fry KD; Tainsky MA; Nicolson GL; Roth JA
    Cancer Res; 1989 May; 49(9):2312-9. PubMed ID: 2650864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells.
    Rettig WJ; Garin-Chesa P; Beresford HR; Oettgen HF; Melamed MR; Old LJ
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3110-4. PubMed ID: 2896356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody against human fibroblasts recognizes a cell surface antigen with increased expression in immortal cell lines.
    Armstrong LS; Edmondson JM; Martinez AO
    In Vitro Cell Dev Biol; 1987 Dec; 23(12):801-2. PubMed ID: 3693247
    [No Abstract]   [Full Text] [Related]  

  • 18. Human fibroblasts from cancer patients: lifespan and transformed phenotype in vitro and role of mesenchyme in vivo.
    Azzarone B; Chaponnier C; Krief P; Mareel M; Suarez H; Macieira-Coelho A
    Mutat Res; 1988 Jun; 199(2):313-25. PubMed ID: 3374507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
    Holly A; Bujía J; Sanchez-Madrid F
    Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the activation antigen, 4F2, by non-Hodgkin's lymphomas of B-cell phenotype.
    Lewandrowski KB; Medeiros LJ; Harris NL
    Cancer; 1990 Sep; 66(6):1158-64. PubMed ID: 1698116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.